| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 18 | |
| #2 | Australia | 14 | |
| #3 | WIPO (World Intellectual Property Organization) | 3 | |
| #4 | EPO (European Patent Office) | 2 | |
| #5 | United Kingdom | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Organic fine chemistry | |
| #4 | Medical technology | |
| #5 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Heterocyclic compounds | |
| #5 | Climate change adaptation technologies | |
| #6 | Diagnosis and surgery | |
| #7 | Object sterilising |
| # | Name | Total Patents |
|---|---|---|
| #1 | Peters Kevin | 20 |
| #2 | Shalwitz Robert | 16 |
| #3 | Peters Kevin Gene | 10 |
| #4 | Gray Jeffrey Lyle | 4 |
| #5 | Clark Cynthia Monesa | 4 |
| #6 | Janusz John | 3 |
| #7 | Nichols Ryan | 3 |
| #8 | Flynn Michael Allen | 3 |
| #9 | Amarasinghe Kande K D | 2 |
| #10 | Ryan Nichols | 2 |
| Publication | Filing date | Title |
|---|---|---|
| GB202009592D0 | Formulations of tie-2 activators and methods of use thereof | |
| US2020338048A1 | Tie-2 activators targeting the schlemm's canal | |
| WO2020214851A1 | Methods of treating hypertension with activators of tie-2 | |
| WO2020068653A1 | MULTISPECIFIC ANTIBODIES THAT TARGET HPTP - β (VE-PTP) AND VEGF | |
| AU2016203254A1 | Methods for treating vascular leak syndrome | |
| AU2014202211A1 | Methods for treating vascular leak syndrome | |
| AU2012323856A1 | Methods for treating Vascular Leak Syndrome and cancer | |
| AU2012200253A1 | Human protein tyrosine phosphatase inhibitors and methods of use |